Kevin D Smith

Title: Kevin D Smith: Innovator in Anti-TNF Antibody Manufacturing

Introduction

Kevin D Smith is a notable inventor based in Philadelphia, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of anti-TNF antibody compositions. With a total of 4 patents, his work has advanced the understanding and manufacturing methods of these important therapeutic agents.

Latest Patents

Kevin's latest patents include innovative methods for producing anti-TNF antibodies. One of his patents focuses on manufacturing methods for producing anti-TNF antibody compositions. This invention relates to methods of manufacture for producing a recombinant anti-TNF antibody, which includes a heavy chain (HC) comprising amino acid sequence SEQ ID NO:36 and a light chain (LC) comprising amino acid sequence SEQ ID NO:37. Additionally, he has developed methods for producing a recombinant anti-TNF antibody with a heavy chain comprising SEQ ID NO:38 and a light chain comprising SEQ ID NO:37.

Career Highlights

Kevin D Smith is currently employed at Janssen Biotech, Inc., where he continues to innovate in the field of biotechnology. His work has been instrumental in advancing therapeutic options for patients suffering from conditions related to tumor necrosis factor (TNF).

Collaborations

Throughout his career, Kevin has collaborated with talented individuals such as Kristopher Barnthouse and Subinay Ganguly. These collaborations have further enriched his research and development efforts.

Conclusion

Kevin D Smith is a prominent figure in the biotechnology sector, with a focus on anti-TNF antibody manufacturing. His contributions through patents and collaborations have significantly impacted the field, paving the way for future innovations.